All Brands Owned by Novo Nordisk
Novo Nordisk owns 2 brands in our database. Browse the complete portfolio of Novo Nordisk subsidiaries and brands across various industries.
Company Type
public
Headquarters
Copenhagen, Denmark
Brand Portfolio
2 brands
Stock
NASDAQ: NVO
Filter by Category
Complete Brand Portfolio
Ozempic
Owned by Novo Nordisk
Prescription diabetes medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.
Wegovy
Owned by Novo Nordisk
Prescription weight loss medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.
About Novo Nordisk
Novo Nordisk is a Danish multinational pharmaceutical company founded in 1923 by Harald Pedersen, headquartered in Copenhagen, Denmark. Under CEO Mike Doustdar, Novo Nordisk trades on NASDAQ (NVO) and is a global leader in diabetes care and obesity treatment. The company reported 2025 sales growth of 10% to DKK 309 billion with operating profit growth of 6%, forecasting 2026 adjusted sales growth of -5% to -13% due to pricing pressures and competition in the GLP-1 market.
Stock Information
Competitors to Novo Nordisk
No competing brands found in the same categories. This could be because Novo Nordiskoperates in unique market segments or we're still building our competitor database.
Novo Nordisk Brand Portfolio Overview
Novo Nordisk maintains a diverse portfolio of 2 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 2 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Novo Nordiskprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Novo Nordisk
Latest News About Novo Nordisk
Articles About Novo Nordisk
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Monthly IPO Roundup: July 2026 — June's Biggest Listings
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
Monthly M&A Roundup: June 2026 Brand Ownership Changes
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.